---
title: "RINGPU obtained a new veterinary drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259472449.md"
description: "RINGPU recently obtained a new veterinary drug registration certificate issued by the Ministry of Agriculture and Rural Affairs, involving a four-in-one inactivated vaccine for Newcastle disease, infectious bronchitis, avian influenza (H9 subtype), and infectious bursal disease. This product fills a gap in the domestic market, demonstrating the company's innovative capabilities in the poultry vaccine field, further consolidating its market position, and will bring new performance growth points for the company"
datetime: "2025-09-30T08:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259472449.md)
  - [en](https://longbridge.com/en/news/259472449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259472449.md)
---

# RINGPU obtained a new veterinary drug registration certificate

According to the announcement from Zhitong Finance APP, RINGPU (300119.SZ) has released a notice stating that, in accordance with the "Regulations on Veterinary Drugs" and the "Measures for the Registration of Veterinary Drugs," the company and its subsidiaries, Tianjin RINGPU Biotechnology Co., Ltd. Airport Economic Zone Branch, RINGPU (Baoding) Biopharmaceutical Co., Ltd., and Guangzhou South China Agricultural University Biopharmaceutical Co., Ltd., have recently obtained the "New Veterinary Drug Registration Certificate" issued by the Ministry of Agriculture and Rural Affairs. The name of the new veterinary drug is: Inactivated vaccine for Newcastle disease, infectious bronchitis, avian influenza (H9 subtype), and infectious bursal disease (LaSota strain + RPVA0406 strain + TJ-4 strain + RPVA0706 strain).

The approval of this product fills the market gap for QX-type infectious bronchitis virus multivalent vaccines for chickens in China, reflecting the company's forward-looking layout and innovative strength in the field of poultry vaccines, improving the company's poultry vaccine product line, helping to further consolidate the company's leading position in the poultry vaccine sector, and will bring new performance growth points for the company

### Related Stocks

- [300119.CN](https://longbridge.com/en/quote/300119.CN.md)

## Related News & Research

- [Barnes & Noble CEO is fine with stocking AI-written books — if they're labeled. The internet had thoughts.](https://longbridge.com/en/news/287084103.md)
- [Dahlonega Now a ‘Gig-Ready’ Community from Kinetic’s Fiber-Optic Network Expansion](https://longbridge.com/en/news/287079090.md)
- [Allen & Heath Rolls Out New SQ+ Lineup of Digital Mixers Announced; First Look YouTube Video on SQ5+,   SQ6+, and   SQ7+ Digital Mixers at B&H](https://longbridge.com/en/news/287101198.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [10:00 ETHill's Pet Nutrition Announces 2026 Hill's Global Symposium - "Healthy Skin Starts From Within" - Exploring the Gut-Skin Axis](https://longbridge.com/en/news/286926460.md)